Standardised single-use tech, the industry’s 'holy grail?'
Vendors say they are open to considering a singular, industry-wide design for disposable bioreactor equipment, IP concerns and customised demands could impede its adoption.
Vendors say they are open to considering a singular, industry-wide design for disposable bioreactor equipment, IP concerns and customised demands could impede its adoption.
WuXi Biologics says its 30,000L capacity single-use facility in China has commenced making products for its partner Tesaro.
Cell Therapy Manufacturing & Gene Therapy Congress
Cell therapies have reached their 'teenage years' and must now overcome processing efficiencies and quality struggles, say industry delegates.